Binhui Biotech Funding: $537M Raised, Series B (2022)
Binhui Biotech is based in Wuhan, China. It has raised $537M in total funding. Latest round: Series B.
Binhui Biotech funding overview
Binhui Biotech is based in Wuhan, China. Binhui Biotech has raised $537M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in April 2022. The round record for Binhui Biotech runs through 2022; nothing later has been disclosed. Investors on record include Yangtze River Pharmaceutical Group, DNV Capital, Jointown Pharmaceutical Group, Ming Capital, Hubei Provincial High-Tech Industry Investment Group. 5 distinct backers are named across the disclosed rounds.
Binhui Biotech at a glance
Total raised
$537M
Latest round
Series B
Latest round date
April 2022
Headquarters
Wuhan, China
Notable investors
Yangtze River Pharmaceutical Group, DNV Capital, Jointown Pharmaceutical Group, Ming Capital, Hubei Provincial High-Tech Industry Investment Group
Frequently asked about Binhui Biotech funding
How much has Binhui Biotech raised?
Binhui Biotech has raised $537M in total disclosed funding across the rounds on record.
Who has invested in Binhui Biotech?
Yangtze River Pharmaceutical Group, DNV Capital, Jointown Pharmaceutical Group, Ming Capital, Hubei Provincial High-Tech Industry Investment Group are named among the investors backing Binhui Biotech.
What was the latest Binhui Biotech funding round?
The most recent disclosed round is a Series B, announced in April 2022.
Where is Binhui Biotech based?
Binhui Biotech is based in Wuhan, China.
When did Binhui Biotech last raise?
The last disclosed Binhui Biotech round closed in April 2022 at Series B.
Binhui Biotech totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Wuhan below to benchmark round size and investor mix.
